The Monash Institute of Pharmaceutical Sciences (MIPS)
Our research areas
-
Drug Discovery Biology
Deep understanding of drug targets to enable the design and development of better medicines.
-
Medicinal Chemistry
The design and synthesis of bioactive molecules for chemical-biology and drug discovery.
-
Drug Delivery Disposition and Dynamics
Next-generation drug-delivery systems to enhance drug exposure and action.
-
Centre for Drug Candidate Optimisation
Translating ligands into drugs by optimising ADME and pharmacokinetic properties.
MIPS advisory board member Mark Noe from Pfizer explains the drug discovery process
CBNS
Headquartered at MIPS, the ARC Centre of Excellence in Bio-Nano Science and Technology (CBNS) is a national innovator in bio-nano sciences and an incubator of the expertise and technological excellence required to develop next generation bio-responsive nanomaterials.
Latest news
-
Monash Institute of Pharmaceutical Sciences ranked second in the world for Clarivate Analytics 2018 Highly Cited Researchers in Pharmacology and Toxicology
29 November, 2018
-
Prof Mark Febbraio to Join Monash Institute of Pharmaceutical Sciences, Monash University
27 November, 2018
-
MIPS research discovers new activation process for G protein coupled-receptors
18 October, 2018
Research seminars
Explore current aspects of pharmaceutical sciences at our regular Wednesday seminars.
Positions available
Access currently available post doctoral, early career research and faculty positions.
@MIPS_Australia
RT @markfebbraio: @MIPS_Australia He might start to age now that he has to deal with a recent recruit who I am told has such an effect on p…
@MIPS_Australia
RT @KMcconalogue: @JoeNicolazzo @MIPS_Australia It's confirmed. He's discovered the fountain of youth. We'll search the lab. We're going to…
@MIPS_Australia
RT @JoeNicolazzo: @MIPS_Australia He looks younger now than in 1997 when he taught us undergrads pharmacokinetics!